These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20948296)

  • 1. p53: guardian of reprogramming.
    Menendez S; Camus S; Izpisua Belmonte JC
    Cell Cycle; 2010 Oct; 9(19):3887-91. PubMed ID: 20948296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 switches off pluripotency on differentiation.
    Lin T; Lin Y
    Stem Cell Res Ther; 2017 Feb; 8(1):44. PubMed ID: 28241890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 connects tumorigenesis and reprogramming to pluripotency.
    Tapia N; Schöler HR
    J Exp Med; 2010 Sep; 207(10):2045-8. PubMed ID: 20876313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming.
    Gong L; Pan X; Chen H; Rao L; Zeng Y; Hang H; Peng J; Xiao L; Chen J
    Sci Rep; 2016 Nov; 6():37281. PubMed ID: 27874035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
    Ong ALC; Ramasamy TS
    Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
    Yi L; Lu C; Hu W; Sun Y; Levine AJ
    Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency.
    Menendez S; Camus S; Herreria A; Paramonov I; Morera LB; Collado M; Pekarik V; Maceda I; Edel M; Consiglio A; Sanchez A; Li H; Serrano M; Belmonte JC
    Aging Cell; 2012 Feb; 11(1):41-50. PubMed ID: 21981310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p53 in limiting somatic cell reprogramming.
    Liu Y; Hoya-Arias R; Nimer SD
    Cell Res; 2009 Nov; 19(11):1227-8. PubMed ID: 19881523
    [No Abstract]   [Full Text] [Related]  

  • 9. MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.
    Ye D; Wang G; Liu Y; Huang W; Wu M; Zhu S; Jia W; Deng AM; Liu H; Kang J
    Stem Cells; 2012 Aug; 30(8):1645-54. PubMed ID: 22696098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
    Ying SY; Fang W; Lin SL
    Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
    Kawamura T; Suzuki J; Wang YV; Menendez S; Morera LB; Raya A; Wahl GM; Izpisúa Belmonte JC
    Nature; 2009 Aug; 460(7259):1140-4. PubMed ID: 19668186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.
    Marión RM; Strati K; Li H; Murga M; Blanco R; Ortega S; Fernandez-Capetillo O; Serrano M; Blasco MA
    Nature; 2009 Aug; 460(7259):1149-53. PubMed ID: 19668189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.
    Jiang J; Lv W; Ye X; Wang L; Zhang M; Yang H; Okuka M; Zhou C; Zhang X; Liu L; Li J
    Cell Res; 2013 Jan; 23(1):92-106. PubMed ID: 23147797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and senescence: learning the biology to improve the technology.
    Banito A; Gil J
    EMBO Rep; 2010 May; 11(5):353-9. PubMed ID: 20379220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells.
    Shi H; Fu Q; Li G; Ren Y; Hu S; Ni W; Guo F; Shi M; Meng L; Zhang H; Qiao J; Guo Z; Chen C
    Cell Reprogram; 2015 Dec; 17(6):441-52. PubMed ID: 26580119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-facilitated miR-199a-3p regulates somatic cell reprogramming.
    Wang J; He Q; Han C; Gu H; Jin L; Li Q; Mei Y; Wu M
    Stem Cells; 2012 Jul; 30(7):1405-13. PubMed ID: 22553189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells.
    Stepniewski J; Pacholczak T; Skrzypczyk A; Ciesla M; Szade A; Szade K; Bidanel R; Langrzyk A; Grochowski R; Vandermeeren F; Kachamakova-Trojanowska N; Jez M; Drabik G; Nakanishi M; Jozkowicz A; Dulak J
    IUBMB Life; 2018 Feb; 70(2):129-142. PubMed ID: 29316264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology.
    Laplane L; Beke A; Vainchenker W; Solary E
    Stem Cells; 2015 Oct; 33(10):2887-92. PubMed ID: 26179060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming.
    Armstrong LC; Westlake G; Snow JP; Cawthon B; Armour E; Bowman AB; Ess KC
    Hum Mol Genet; 2017 Dec; 26(23):4629-4641. PubMed ID: 28973543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats.
    Miura K; Oiwa Y; Kawamura Y
    Adv Exp Med Biol; 2021; 1319():329-339. PubMed ID: 34424523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.